FILTER

FILTERED INTERVIEW RESULTS

Fabio Fiscaletti

CEO, MASTELLI
Mastelli is a small Italian pharma company with bold plans for expansion.

Michele Diaferia

CEO, ITEL GROUP
Itel Group describes the on-going development of its proton linear accelerator.

Nanding Zhao

CEO, NERVIANO MEDICAL SCIENCES (NMS) GROUP
NMS is one of the largest kinase inhibitors-focused oncology drug discovery companies in Italy.

Giovanni Mariani

CEO, LISAPHARMA
Lisapharma describes the challenges Italian pharma producers have experienced over the past two years.

Rocco Pavese

CEO, GENETIC SPA
Genetic is an Italian CDMO founded in 2007 dedicated to the research and development, manufacturing, licensing-out and marketing of medicines.

Alessia Valducci

CEO, VALPHARMA
Valpharma is an Italian CMO involved in pharmaceutical development and contract manufacturing specializing in solid oral dosage medicines and nutraceuticals, both developed with modified-release technologies.

Pasquale de Blasio

FOUNDER, INTEGRATED SYSTEMS ENGINEERING (ISE)
Integrated Systems Engineering sets out its objectives to develop its TMA technology and move it into diagnostics and to build a biobank of organoids.

Massimo Versace

COUNTRY MANAGER, SUN PHARMA ITALY
Sun Pharma discusses its’ operations in Italy.

Giorgio Palu

PRESIDENT, AIFA
The Italian Medical Agency (AIFA) explains the current issues facing Italy’s life science industry.

Pierfrancesco Morosini

CEO, ICROM
Icrom is an Italian CDMO leader for the production of APIs and GMP intermediates.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2024 - Pre-release

The pre-release edition of Africa Energy 2024 comprises analysis based on over 80 interviews with ministers and leading executives from IOCs, NOCs, independents, associations, investors and service providers, to provide an in-depth and holistic view of sub-Saharan Africa’s ever-evolving energy sector.

PARTNER EVENTS